Am J Perinatol 2024; 41(10): 1285-1289
DOI: 10.1055/a-2278-8948
SMFM Fellowship Series Article

Neonatal Outcomes Are Similar between Patients with Resolved and Those with Persistent Oligohydramnios

1   Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Massachusetts Chan Medical School, Worcester, Massachusetts
,
Phinnara Has
2   Lifespan Health System, Department of Biostatistics, Epidemiology, and Research Design, Providence, Rhode Island
,
David A. Savitz
3   Department of Epidemiology, Brown University School of Public Health, Providence, Rhode Island
5   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, Rhode Island
,
4   Yale University, Department of Internal Medicine, Center for Outcomes Research and Evaluation, New Haven, Connecticut
,
Adam K. Lewkowitz
5   Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Women & Infants Hospital of Rhode Island, Alpert Medical School of Brown University, Providence, Rhode Island
› Institutsangaben

Funding National Institute of Child Health and Human Development grant 1R01HD077592, principal investigator: D.A.S., Title: Effect of Iatrogenic Delivery at 34 to 38 weeks' gestation on pregnancy outcome.
Preview

Abstract

Objective Oligohydramnios (defined as amniotic fluid volume < 5 cm or deepest vertical pocket < 2 cm) is regarded as an ominous finding on prenatal ultrasound. Amniotic fluid, however, is not static, and to date, there have been no studies comparing perinatal outcomes in patients who are diagnosed with oligohydramnios that resolves and those who have persistent oligohydramnios.

Study Design This is a secondary analysis of a National Institutes of Health–funded retrospective cohort study of singleton gestations delivered at a tertiary care hospital between 2002 and 2013 with mild hypertensive disorders and/or fetal growth restriction (FGR). Maternal characteristics, delivery, and neonatal information were abstracted by trained research nurses. Patients with a diagnosis of oligohydramnios were identified, and those with resolved versus persistent oligohydramnios at the time of delivery were compared. The primary outcome was a composite of neonatal resuscitation at delivery: administration of oxygen, bag–mask ventilation, continuous positive airway pressure, intubation, chest compression, or cardiac medication administration. Secondary outcomes included FGR, timing, and mode of delivery.

Results Of 527 women meeting study criteria, 42 had oligohydramnios that resolved prior to delivery, whereas 485 had persistent oligohydramnios. There were no significant differences in patient demographics between groups. The gestational age at diagnosis was significantly lower for patients with resolved versus persistent oligohydramnios (median: 33.0 [interquartile range, IQR: 29.1–35.9] vs. 38.0 [IQR: 36.4–39.3], p < 0.001). There was not a substantial difference in rate of neonatal resuscitation (41 vs. 32%, p = 0.31). Patients with resolved oligohydramnios were more likely to have developed FGR than those with persistent oligohydramnios (55 vs. 36%, p < 0.02). There were no significant differences for gestational age at delivery, birth weight, or neonatal intensive care unit admission.

Conclusion Patients whose oligohydramnios resolved were diagnosed earlier yet had similar rates of neonatal resuscitation but higher rates of FGR than those who had persistent oligohydramnios.

Key Points

  • When diagnosed earlier in pregnancy, oligohydramnios was more likely to resolve prenatally.

  • Patients who were diagnosed with oligohydramnios earlier in pregnancy had higher rates of FGR.

  • There were no differences in the rates of the composite outcome of need for neonatal resuscitation when comparing those with resolved versus those with persistent oligohydramnios. No differences in composite neonatal morbidity were noted between those with resolved versus persistent oligohydramnios.

Note

This study is presented as a poster at the 41st Annual Scientific Meeting for the Society of Maternal Fetal Medicine, Virtual Format, January 25–30, 2021.




Publikationsverlauf

Eingereicht: 03. März 2022

Angenommen: 26. Februar 2024

Accepted Manuscript online:
29. Februar 2024

Artikel online veröffentlicht:
26. März 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA